CAPITAL IMPACT ADVISORS, LLC – Apellis Pharmaceuticals, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$604,000
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.95% | 659 shares | 3K | $68.3 | 13.95K |
| Q2 2022 | share | Increase | 0.00% | 13.3K shares | 601K | $45.22 | 13.3K |